@article{2428ca94e224430cb0b43eca7dc02dbd,
title = "Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer",
keywords = "Breast cancer, Neoadjuvant chemotherapy, Disease-free survival, Overall survival, SURGICAL ADJUVANT BREAST, CELL-DEATH, PHASE-III, DOCETAXEL, DOXORUBICIN, TRIAL, DOXORUBICIN/CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE, ANTHRACYCLINE, THERAPY",
author = "Vriens, {B. E. P. J.} and Vriens, {I. J. H.} and Aarts, {M. J. B.} and {van Gastel}, {S. M.} and {van den Berkmortel}, {F. W. P. J.} and Smilde, {T. J.} and {van Warmerdam}, {L. J. C.} and {van Spronsen}, {D. J.} and Peer, {P. G. M.} and {de Boer}, M. and Tjan-Heijnen, {V. C. G.} and {Breast Canc Trialists Grp}",
year = "2017",
month = oct,
doi = "10.1007/s10549-017-4364-8",
language = "English",
volume = "165",
pages = "593--600",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer, Cham",
number = "3",
}